📖

GFAP (Glial Fibrillary Acidic Protein) - Biomarker

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-biomarkers-gfap-glial-fibrillary-ac
Related Entities
biomarkers-gfap-glial-fibrillary-acidic-protein
Metadata
slugbiomarkers-gfap-glial-fibrillary-acidic-protein
entity_typebiomarker
kg_node_idNone
🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (131)
related🧪GFAP-Positive Reactive Astrocyte Subtype Delineation90%
mentions🧫iPSC-NPC effects on astrocytes in vitro ICH model80%
mentions🧫Blood Biomarker vs Tau PET for Treatment Monitoring80%
mentions🔬Neuroinflammation and microglial priming in early Alzheimer&75%
related🧫iPSC-NPC effects on astrocytes in vitro ICH model72%
related🧫Blood Biomarker vs Tau PET for Treatment Monitoring72%
mentions🧪GFAP-Positive Reactive Astrocyte Subtype Delineation70%
mentions🧫GWAS of composite biomarker score70%
mentions🧫Plasma ATN biomarkers across AD continuum in Chilean cohort70%
mentions🧫Real-world safety study of Lecanemab in Japanese AD patients70%
mentions🧫iPSC-NPC transplantation in ICH animal model70%
mentions🧫GWAS of plasma GFAP in East Asian cohort70%
mentions🧫Proposed experiment from debate on Astrocytes adopt A1 (neur70%
mentions🧫s:** - ALOX15 overexpression in healthy astrocytes should be70%
mentions🧫Proposed experiment from debate on Epigenetic clocks and bio70%
mentions🧫s:** - Compare tau strain spreading in EXT1/EXT2 conditional70%
mentions🧫s:** - Dose-response studies showing therapeutic window with70%
mentions🧫Proposed experiment from debate on Microglia activate astroc70%
mentions🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi70%
mentions🧫Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti70%
mentions🧫Anti-Tau Immunotherapy Dosing Optimization70%
mentions🧫ApoE4 Function in Alzheimer's Disease70%
mentions🧫Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&70%
mentions🧫Blood-Based Biomarker Panel for Early AD Detection70%
mentions🧫Cognitive Reserve Mechanisms in Alzheimer's Disease — M70%
mentions🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i70%
mentions🧫Down Syndrome Alzheimer's Disease: Mechanisms and Thera70%
mentions🧫Frontal and Temporal Lobe Selective Vulnerability in FTD — M70%
mentions🧫FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation70%
mentions🧫Lifestyle Intervention Mechanisms in Alzheimer's Diseas70%
mentions🧫Neural Stem Cell Therapy for Alzheimer's Disease70%
mentions🧫Normal Aging to Alzheimer's Disease Transition Trigger 70%
mentions🧫CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs 70%
mentions🧫Presymptomatic GRN Carrier Intervention Timing — Biomarker-G70%
mentions🧫PSP and CBS Biomarker Validation Study70%
mentions🧫SCFA-Mediated Neuroinflammation in Alzheimer's Disease70%
mentions🧫Sex Differences in Alzheimer's Disease — mechanisms and70%
mentions🧫Traumatic Brain Injury and Alzheimer's Disease Relation70%
mentions🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal70%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
related🧫Animal Model Comparison for Neurodegenerative Disease Therap70%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#70%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&70%
related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag70%
related🧫Neural Oscillation Dysfunction Validation in Parkinson'70%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#70%
related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin70%
related🧫Protein Aggregation Kinetic Validation Results70%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson70%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise70%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di70%
related🧫Experiment Validation: In vitro ThT Assay70%
related🧫Macroautophagy Dysfunction in PD - Experiment Design70%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
related🧫Blood Biomarker vs Tau PET for Treatment Monitoring70%
related🧫Animal Model Comparison for Neurodegenerative Disease Therap70%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#70%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&70%
related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag70%
related🧫Neural Oscillation Dysfunction Validation in Parkinson'70%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#70%
related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin70%
related🧫Protein Aggregation Kinetic Validation Results70%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson70%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise70%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di70%
related🧫Experiment Validation: In vitro ThT Assay70%
related🧫Macroautophagy Dysfunction in PD - Experiment Design70%
related🔬Neuroinflammation and microglial priming in early Alzheimer&67%
related🧫GWAS of composite biomarker score63%
related🧫Plasma ATN biomarkers across AD continuum in Chilean cohort63%
related🧫Real-world safety study of Lecanemab in Japanese AD patients63%
related🧫iPSC-NPC transplantation in ICH animal model63%
related🧫GWAS of plasma GFAP in East Asian cohort63%
related🧫Proposed experiment from debate on Astrocytes adopt A1 (neur63%
related🧫s:** - ALOX15 overexpression in healthy astrocytes should be63%
related🧫Proposed experiment from debate on Epigenetic clocks and bio63%
related🧫s:** - Compare tau strain spreading in EXT1/EXT2 conditional63%
related🧫s:** - Dose-response studies showing therapeutic window with63%
related🧫Proposed experiment from debate on Microglia activate astroc63%
related🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi63%
related🧫Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti63%
related🧫Anti-Tau Immunotherapy Dosing Optimization63%
related🧫ApoE4 Function in Alzheimer's Disease63%
related🧫Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&63%
related🧫Blood-Based Biomarker Panel for Early AD Detection63%
related🧫Cognitive Reserve Mechanisms in Alzheimer's Disease — M63%
related🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i63%
related🧫Down Syndrome Alzheimer's Disease: Mechanisms and Thera63%
related🧫Frontal and Temporal Lobe Selective Vulnerability in FTD — M63%
related🧫FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation63%
related🧫Lifestyle Intervention Mechanisms in Alzheimer's Diseas63%
related🧫Neural Stem Cell Therapy for Alzheimer's Disease63%
related🧫Normal Aging to Alzheimer's Disease Transition Trigger 63%
related🧫CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs 63%
related🧫Presymptomatic GRN Carrier Intervention Timing — Biomarker-G63%
related🧫PSP and CBS Biomarker Validation Study63%
related🧫SCFA-Mediated Neuroinflammation in Alzheimer's Disease63%
related🧫Sex Differences in Alzheimer's Disease — mechanisms and63%
related🧫Traumatic Brain Injury and Alzheimer's Disease Relation63%
related🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal63%
mentions🧪Glial Glycocalyx Remodeling Therapy50%
mentions🧪Heat Shock Protein 70 Disaggregase Amplification50%
mentions🧪Serine/Arginine-Rich Protein Kinase Modulation50%
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%
related🔬What are the mechanisms underlying 4r-tau strain-specific sp50%
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
related🔬What are the mechanisms underlying protein aggregation cross50%
related🔬What are the mechanisms underlying rna binding protein dysre50%
related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%
related🔬RNA binding protein dysregulation across ALS FTD and AD50%
related🧪Mitochondrial-Lysosomal Contact Site Engineering50%
related🧪Lysosomal Membrane Repair Enhancement50%
related🧪Lysosomal Calcium Channel Modulation Therapy50%
related🧪Lysosomal Enzyme Trafficking Correction50%
related🧪Optogenetic Control of Mitochondrial Transfer Networks50%
mentions📖department-of-defense40%
mentions🔬What are the mechanisms underlying digital biomarkers and ai40%
mentions🔬What are the mechanisms underlying protein aggregation cross40%
mentions🔬What are the mechanisms underlying rna binding protein dysre40%
mentions🔬RNA binding protein dysregulation across ALS FTD and AD40%
related🧪Heat Shock Protein 70 Disaggregase Amplification40%
related🧪Glial Glycocalyx Remodeling Therapy40%
related🧪Serine/Arginine-Rich Protein Kinase Modulation40%
related🧪The Glial Ketone Metabolic Shunt Hypothesis35%
related🧪Glial Glycocalyx Remodeling Therapy35%
related🧪APOE Isoform Expression Across Glial Subtypes35%
related🔬What are the mechanisms underlying 4r-tau strain-specific sp30%
related🔬How does metabolic reprogramming (glucose metabolism shifts,27%